These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 8161475
21. Role of endothelin in chronic renal failure--developments in renal involvement. Richter CM. Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii36-8. PubMed ID: 16987832 [Abstract] [Full Text] [Related]
23. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats. Song J, Meng L, Li S, Qu L, Li X. Vascul Pharmacol; 2009 Jun; 50(5-6):185-93. PubMed ID: 19563735 [Abstract] [Full Text] [Related]
24. Role of podocytes for reversal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition. Ortmann J, Amann K, Brandes RP, Kretzler M, Münter K, Parekh N, Traupe T, Lange M, Lattmann T, Barton M. Hypertension; 2004 Dec; 44(6):974-81. PubMed ID: 15545511 [Abstract] [Full Text] [Related]
25. Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice. Role of endothelin. Chatziantoniou C, Boffa JJ, Ardaillou R, Dussaule JC. J Clin Invest; 1998 Jun 15; 101(12):2780-9. PubMed ID: 9637712 [Abstract] [Full Text] [Related]
26. [Endothelins]. Peco-Antić A. Srp Arh Celok Lek; 1993 Jun 15; 121(3-7):92-4. PubMed ID: 7716647 [Abstract] [Full Text] [Related]
27. Effects of lipids on the pathogenesis of progressive renal failure: role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in the prevention of glomerulosclerosis. Guijarro C, Keane WF. Miner Electrolyte Metab; 1996 Jun 15; 22(1-3):147-52. PubMed ID: 8676808 [Abstract] [Full Text] [Related]
30. Role of endothelin in acute renal failure due to rhabdomyolysis in rats. Karam H, Bruneval P, Clozel JP, Löffler BM, Bariéty J, Clozel M. J Pharmacol Exp Ther; 1995 Jul 15; 274(1):481-6. PubMed ID: 7616435 [Abstract] [Full Text] [Related]
33. Physiologic and pathophysiologic roles of endothelin in the kidney. Clavell AL, Burnett JC. Curr Opin Nephrol Hypertens; 1994 Jan 15; 3(1):66-72. PubMed ID: 7850414 [Abstract] [Full Text] [Related]
34. Endothelin antagonists and resistant hypertension in chronic kidney disease. Moore R, Linas S. Curr Opin Nephrol Hypertens; 2010 Sep 15; 19(5):432-6. PubMed ID: 20502329 [Abstract] [Full Text] [Related]
35. Pathophysiological role of vascular endothelial growth factor in the remnant kidney. Schrijvers BF, Flyvbjerg A, Tilton RG, Rasch R, Lameire NH, De Vriese AS. Nephron Exp Nephrol; 2005 Sep 15; 101(1):e9-15. PubMed ID: 15925906 [Abstract] [Full Text] [Related]
36. Progressive glomerulosclerosis and renal failure following perinatal gamma radiation in the beagle. Jaenke RS, Phemister RD, Norrdin RW. Lab Invest; 1980 Jun 15; 42(6):643-55. PubMed ID: 7392570 [Abstract] [Full Text] [Related]
37. Renal effects and mesangial cell contraction induced by endothelin are mediated by PAF. López-Farré A, Gómez-Garre D, Bernabeu F, Montañés I, Millás I, López-Novoa JM. Kidney Int; 1991 Apr 15; 39(4):624-30. PubMed ID: 2051719 [Abstract] [Full Text] [Related]
38. Influence of factors in the digestive tract on the progression of chronic renal failure. Takahashi S, Okada K, Shimamura T. Nihon Jinzo Gakkai Shi; 1993 Jan 15; 35(1):1-11. PubMed ID: 8336393 [Abstract] [Full Text] [Related]